Literature DB >> 17356103

Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis.

Adel M Assaad1, Steven M Kawut2, Selim M Arcasoy2, Erika B Rosenzweig3, Jessie S Wilt2, Joshua R Sonett4, Alain C Borczuk5.   

Abstract

BACKGROUND: Pulmonary capillary hemangiomatosis (PCH) is a rare cause of pulmonary arterial hypertension with no effective medical therapy and a high risk of mortality. The pathogenesis of PCH is unknown.
METHODS: We used gene expression analysis to compare lung tissue samples from two patients with PCH to those from seven control subjects. The nodules of proliferating capillaries in PCH patients were needle microdissected from cryostat sections. RNA extraction and labeling were followed by hybridization to U95Av2 oligonucleotide arrays (Affymetrix; Santa Clara, CA). In situ hybridization and immunohistochemistry were also performed.
RESULTS: The gene expression profile of PCH allowed for unsupervised clustering from the profile of the lung tissue samples of control subjects. Platelet-derived growth factor (PDGF)-B gene (PDGFB), PDGF receptor (PDGFR)-beta gene (PDGFR-beta), mast cell-related genes, and type 2 pneumocyte-related genes were found to be overexpressed in PCH lesions. In situ hybridization as well as immunohistochemistry for PDGFB showed expression by type 2 pneumocytes and endothelial cells. Immunohistochemical staining for PDGFR-beta localized to pericytic/vascular smooth muscle cells surrounding the proliferating capillaries. CD117 staining confirmed an abundance of mast cells in the lesions, which also stained heavily for PDGFR-beta.
CONCLUSIONS: The expression of the PDGFB and PDGFR-beta genes characterizes the nodular proliferations of PCH. Increased numbers of mast cells, pericytes, and type II pneumocytes accompany the endothelial proliferation. The up-regulation of these important angiogenic and antiapoptotic genes suggests a mechanism and potential therapeutic approaches for PCH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356103     DOI: 10.1378/chest.06-1680

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

Review 1.  What can imaging tell us about physiology? Lung growth and regional mechanical strain.

Authors:  Connie C W Hsia; Merryn H Tawhai
Journal:  J Appl Physiol (1985)       Date:  2012-05-10

2.  Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment.

Authors:  Danny Jonigk; Heiko Golpon; Clemens L Bockmeyer; Lavinia Maegel; Marius M Hoeper; Jens Gottlieb; Nils Nickel; Kais Hussein; Ulrich Maus; Ulrich Lehmann; Sabina Janciauskiene; Tobias Welte; Axel Haverich; Johanna Rische; Hans Kreipe; Florian Laenger
Journal:  Am J Pathol       Date:  2011-05-11       Impact factor: 4.307

3.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

4.  A 7-year-old with pulmonary hypertension.

Authors:  James Olin; Steven Abman; R Grady; D Ivy; Mark Lovell; David Partrick; Vivek Balasubramaniam
Journal:  BMJ Case Rep       Date:  2011-04-20

5.  Imatinib for the treatment of pulmonary arterial hypertension and pulmonary capillary hemangiomatosis.

Authors:  Dhruv Nayyar; Kavitha Muthiah; Gayathri Kumarasinghe; Ravin Hettiarachchi; David Celermajer; Eugene Kotlyar; Anne Keogh
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

6.  EIF2AK4 mutations in pulmonary capillary hemangiomatosis.

Authors:  D Hunter Best; Kelli L Sumner; Eric D Austin; Wendy K Chung; Lynette M Brown; Alain C Borczuk; Erika B Rosenzweig; Pinar Bayrak-Toydemir; Rong Mao; Barbara C Cahill; Henry D Tazelaar; Kevin O Leslie; Anna R Hemnes; Ivan M Robbins; C Gregory Elliott
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

7.  Familial pulmonary capillary hemangiomatosis early in life.

Authors:  Johannes Wirbelauer; Helge Hebestreit; Alexander Marx; Eugene J Mark; Christian P Speer
Journal:  Case Rep Pulmonol       Date:  2011-12-19

8.  Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study.

Authors:  Maria J Overbeek; Anco Boonstra; Alexandre E Voskuyl; Madelon C Vonk; Anton Vonk-Noordegraaf; Maria P A van Berkel; Wolter J Mooi; Ben A C Dijkmans; Laurens S Hondema; Egbert F Smit; Katrien Grünberg
Journal:  Arthritis Res Ther       Date:  2011-04-14       Impact factor: 5.156

9.  Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target

Authors:  Oren Pleniceanu; Racheli Shukrun; Dorit Omer; Einav Vax; Itamar Kanter; Klaudyna Dziedzic; Naomi Pode-Shakked; Michal Mark-Daniei; Sara Pri-Chen; Yehudit Gnatek; Hadas Alfandary; Nira Varda-Bloom; Dekel D Bar-Lev; Naomi Bollag; Rachel Shtainfeld; Leah Armon; Achia Urbach; Tomer Kalisky; Arnon Nagler; Orit Harari-Steinberg; Jack L Arbiser; Benjamin Dekel
Journal:  EMBO Mol Med       Date:  2017-04       Impact factor: 12.137

Review 10.  Pulmonary capillary hemangiomatosis: a focus on the EIF2AK4 mutation in onset and pathogenesis.

Authors:  Lijiang Ma; Ruijun Bao
Journal:  Appl Clin Genet       Date:  2015-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.